Product Information

DABIGATRAN ETEXILATE 150 MG CP is a generic product labeled by Novadoz Pharmaceuticals LLC, priced at $0.7726 per EA under NDC 72205020460. Its NADAC has been published 116 times since Sep 4, 2024.

FDA first approved this application on May 22, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DABIGATRAN ETEXILATE 150 MG CP

DABIGATRAN ETEXILATE
$0.7726per EA

Strength

150 mg/1

NDC

72205020460

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA213879

FDA Approved

5/22/2024

TE Code

AB

On Market Since

5/22/2024

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price Statistics

The NADAC for DABIGATRAN ETEXILATE 150 MG CP has been published 116 times since Sep 4, 2024, and over the history we have for it it has declined 68.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7726 per EA
All-time high$2.4609 (Sep 11, 2024)
All-time low$0.7726 (Nov 18, 2026)
52-week high$1.0310
52-week low$0.7726
Median price$1.1459
Average price$1.2952
Largest weekly change-15.7% (Oct 23, 2024)
Weeks tracked116
Tracking sinceSep 4, 2024

Price History

1W

-3.5%

1M

-2.8%

3M

-6.1%

6M

-10.8%

1Y

-29.1%

3Y

N/A

5Y

N/A

All

-68.6%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DABIGATRAN ETEXILATE 150 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DABIGATRAN ETEXILATE 150 MG CP, manufactured by Novadoz Pharmaceuticals LLC, is $0.7726 per EA (NDC 72205020460), effective Nov 18, 2026.

How has the price of DABIGATRAN ETEXILATE 150 MG CP changed over time?

Over the history we have for it, the NADAC for DABIGATRAN ETEXILATE 150 MG CP has declined 68.6%. It has been tracked across 116 weekly CMS publications since Sep 4, 2024.

What are the highest and lowest recorded NADAC prices for DABIGATRAN ETEXILATE 150 MG CP?

Since Sep 4, 2024, the NADAC for DABIGATRAN ETEXILATE 150 MG CP has ranged from a low of $0.7726 (Nov 18, 2026) to a high of $2.4609 (Sep 11, 2024), with a median of $1.1459 per EA.

Are there cheaper alternatives to DABIGATRAN ETEXILATE 150 MG CP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as DABIGATRAN ETEXILATE 150 MG CP in a comparable dosage form, but none are currently priced below it.

Who manufactures DABIGATRAN ETEXILATE 150 MG CP?

DABIGATRAN ETEXILATE 150 MG CP (NDC 72205020460) is labeled by Novadoz Pharmaceuticals LLC, and CMS classifies it as a generic product.